跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TGCef IV - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
TGCef IV
Approved
STANDARD
TGCef IV
Reyoung Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
78c6308da3b5f232
Company
Reyoung Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
78c6308da3b5f232
Drug Approval Philippines Name
TGCef IV
Product Name
TGCef IV
Registration Number
DRP-11361-03
Brand Name
TGCef IV
Generic Name
Cefuroxime (as sodium)
Dosage Form
Powder for Injection (IM/IV)
Dosage Strength
750 mg
Manufacturer
Reyoung Pharmaceutical Co., Ltd.
Importer
Dreamax Incorporated
Distributor
TGIF Pharmaceutical Trading Inc
Issuance Date
26 April 2023
Expiry Date
04 March 2027
Pharmacologic Category
Antibacterial (Cephalosporin)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
78c6308da3b5f232
Type
Standard
Back to Philippines FDA Approvals